Mark Christopher Rhodes, | |
400 E 3rd St, Duluth, MN 55805-1951 | |
(218) 786-8364 | |
Not Available |
Full Name | Mark Christopher Rhodes |
---|---|
Gender | Male |
Speciality | Otolaryngology |
Experience | 34 Years |
Location | 400 E 3rd St, Duluth, Minnesota |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1538192737 | NPI | - | NPPES |
112528100 | Medicaid | MN | |
32253200 | Medicaid | WI |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Y00000X | Otolaryngology | 38746 (Minnesota) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Essentia Health Duluth | Duluth, MN | Hospital |
Essentia Health St Mary's Medical Center | Duluth, MN | Hospital |
St Marys Hospital Superior | Superior, WI | Hospital |
Essentia Health Virginia | Virginia, MN | Hospital |
Memorial Medical Center | Ashland, WI | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
The Duluth Clinic Ltd | 2567374283 | 932 |
News Archive
Could a chemical produced by the brain that regulates mood, sleep and breathing also be protective in people with epilepsy? New research has found that higher levels of serotonin in the blood after a seizure are linked to a lower incidence of seizure-related breathing problems called apneas, when a person temporarily stops breathing.
The difficulties that many women describe as memory problems when menopause approaches are real, according to a study published today in the journal Menopause, the journal of the North American Menopause Society.
Inspire Pharmaceuticals, Inc. announced today it has entered into an Amended and Restated License, Development and Marketing Agreement with Allergan, Inc., which revises terms related to the PROLACRIA (diquafosol tetrasodium ophthalmic solution) 2% development program and Inspire's right to receive revenues from Allergan based on net sales of RESTASIS (cyclosporine ophthalmic emulsion) 0.05% and any other human ophthalmic formulations of cyclosporine owned or controlled by Allergan.
Pharmaceutical researchers at Oregon State University have developed a new approach to treat eczema and other inflammatory skin disorders that would use individual tests and advanced science to create personalized treatments based on each person's lipid deficiencies.
Discouraging children from drinking fizzy drinks can prevent excessive weight gain, according to new research available on bmj.com.
› Verified 9 days ago
Entity Name | The Duluth Clinic Ltd |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1902563638 PECOS PAC ID: 2567374283 Enrollment ID: O20031103000229 |
News Archive
Could a chemical produced by the brain that regulates mood, sleep and breathing also be protective in people with epilepsy? New research has found that higher levels of serotonin in the blood after a seizure are linked to a lower incidence of seizure-related breathing problems called apneas, when a person temporarily stops breathing.
The difficulties that many women describe as memory problems when menopause approaches are real, according to a study published today in the journal Menopause, the journal of the North American Menopause Society.
Inspire Pharmaceuticals, Inc. announced today it has entered into an Amended and Restated License, Development and Marketing Agreement with Allergan, Inc., which revises terms related to the PROLACRIA (diquafosol tetrasodium ophthalmic solution) 2% development program and Inspire's right to receive revenues from Allergan based on net sales of RESTASIS (cyclosporine ophthalmic emulsion) 0.05% and any other human ophthalmic formulations of cyclosporine owned or controlled by Allergan.
Pharmaceutical researchers at Oregon State University have developed a new approach to treat eczema and other inflammatory skin disorders that would use individual tests and advanced science to create personalized treatments based on each person's lipid deficiencies.
Discouraging children from drinking fizzy drinks can prevent excessive weight gain, according to new research available on bmj.com.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Mark Christopher Rhodes, 400 E 3rd St, Duluth, MN 55805-1951 Ph: (218) 786-8364 | Mark Christopher Rhodes, 400 E 3rd St, Duluth, MN 55805-1951 Ph: (218) 786-8364 |
News Archive
Could a chemical produced by the brain that regulates mood, sleep and breathing also be protective in people with epilepsy? New research has found that higher levels of serotonin in the blood after a seizure are linked to a lower incidence of seizure-related breathing problems called apneas, when a person temporarily stops breathing.
The difficulties that many women describe as memory problems when menopause approaches are real, according to a study published today in the journal Menopause, the journal of the North American Menopause Society.
Inspire Pharmaceuticals, Inc. announced today it has entered into an Amended and Restated License, Development and Marketing Agreement with Allergan, Inc., which revises terms related to the PROLACRIA (diquafosol tetrasodium ophthalmic solution) 2% development program and Inspire's right to receive revenues from Allergan based on net sales of RESTASIS (cyclosporine ophthalmic emulsion) 0.05% and any other human ophthalmic formulations of cyclosporine owned or controlled by Allergan.
Pharmaceutical researchers at Oregon State University have developed a new approach to treat eczema and other inflammatory skin disorders that would use individual tests and advanced science to create personalized treatments based on each person's lipid deficiencies.
Discouraging children from drinking fizzy drinks can prevent excessive weight gain, according to new research available on bmj.com.
› Verified 9 days ago
Michael Mcneal Savage, Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 400 E 3rd St, Duluth, MN 55805 Phone: 218-786-3323 | |
Rolando R Rosas, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 400 E 3rd St, Essentia Health Duluth Clinic, Duluth, MN 55805 Phone: 218-786-8364 | |
Dr. David M Choquette, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 920 E 1st St, Suite 301, Duluth, MN 55805 Phone: 218-279-6279 Fax: 218-279-6280 | |
Dr. Todd J Freeman, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 920 E 1st St, Suite 301, Duluth, MN 55805 Phone: 218-279-6279 Fax: 218-279-6280 | |
Dr. Heidi Elaine L'esperance, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 400 E 3rd St, Duluth, MN 55805 Phone: 218-786-8364 | |
William Portilla, Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 400 E 3rd St, Duluth, MN 55805 Phone: 218-786-8364 |